Project Grant 2451306
Award Date
1/15/25
Completion Date
9/30/25
Dollars Obligated
$299K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02139, USA
Similar Awards
This federal Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), supports the development of a rapid and automated pathogen DNA extraction device from venous whole blood samples. The $274,858 award, effective September 1, 2024 through February 28, 2025, will enable the awardee, New England Hemolytics, Inc., to test and optimize a novel pathogen extraction technology that can decrease the time to...
This $305,000 Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a point-of-care diagnostic platform by Resonantia Diagnostics, Inc. that can rapidly identify pathogens and determine their antimicrobial susceptibility within 60 minutes. The key technical objectives of this 1-year project are to: (1) demonstrate accurate antimicrobial susceptibility testing at low pathogen loads, (2)...
Under a $997,781 cooperative agreement awarded by the National Science Foundation (NSF) through its Technology, Innovation, and Partnerships (CFDA 47.084) program, Nanopath Inc. - a woman-owned small business - is developing an integrated point-of-care system for rapid pathogen identification and characterization. The system utilizes proprietary nanosensor technology to detect target nucleic acid sequences directly from patient samples, eliminating the need for bacterial culture or nucleic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) aims to develop novel nanopore- and click-chemistry-based approaches for the rapid, accurate detection of sepsis-causing pathogens directly from blood, without requiring a positive blood culture. The $1,569,047 award, with a project period from July 1, 2024 to May 31, 2029, will fund the engineering of nanopore biosensors and the...
This $274,362 Project Grant awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel molecular diagnostic platform for detecting respiratory diseases, including strep throat, without the need for an expensive table-top device. The platform aims to provide the accuracy of laboratory-based tests for use by non-healthcare professionals in non-clinical settings, enabling rapid and reliable...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $305,000 to Giant Biosystems Inc., a small disadvantaged and woman-owned business, to develop a rapid point-of-care antimicrobial susceptibility testing (AST) kit. The goal is to create a platform that can generate actionable AST results within 6-9 hours, compared to the 3-5 day turnaround of current methods. This will enable physicians to...
This $984,381 Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports Cobio Diagnostics Inc., a for-profit company in Aurora, Colorado, in developing an expanded diagnostic technology for rapidly identifying and determining antimicrobial susceptibility of major bloodborne bacterial pathogens. The project aims to expand on the company's previous Phase I SBIR work by developing new tests capable of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 supports the development of an automated, AI-supported platform for rapid detection of food pathogens. The key products/services to be delivered include: Building an automated sample preparation module to enhance pathogen enrichment across food groups. Developing an automated experimental design workflow to accelerate the optimization of enrichment time. Using...